Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 12:26 AM
NCT ID:
NCT05671458
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of a malignancy (squamous cell carcinoma (SCC), adenocarcinoma (AC), mucoepidermoid carcinoma (MEC), adenoidcystic carcinoma (ACC)) of the midface, upper jaw and skull-base (e.g. based on imaging-studies and/or biopsies)
* Indication of surgical tumor resection according to multidisciplinary tumor conference
* Probably indication for postoperative radiotherapy (e.g. T3/4 tumor)
* Medical operability and written informed consent of the patient to undergo surgical resection (as indicated clinically)
* Patient age ≥ 18 years
* Karnofsky performance index ≥ 60%
* For women with childbearing potential: adequate contraception
* Ability of subject to understand character and individual consequences of the trial
* Written informed consent to participate in this trial
Exclusion Criteria:
* Contraindications against radiotherapy, especially pregnant or lactating women
* Refusal of the patient to take part in the study
* Participation in another competing clinical study or observation period of competing trials
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05671458
Study Brief:
Protocol Section:
NCT05671458